Adaptimmune TherapeuticsADAP 
$0.58-1.53%24h
-1.53%24h
Global rank18390
Market cap$131.50M
Change 7d-6.61%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Adaptimmune Therapeutics (ADAP)
As of January 2025, Adaptimmune Therapeutics has a market cap of $131.50M. This makes Adaptimmune Therapeutics the world's 18390th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Adaptimmune Therapeutics from 2015 to 2024
-
Value:-
Market cap history of Adaptimmune Therapeutics from 2015 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $279.36M | 55.11% |
| 2023 | $180.11M | -45.68% |
| 2022 | $331.60M | -61.07% |
| 2021 | $851.71M | -30.43% |
| 2020 | $1.22B | 349.17% |
| 2019 | $272.55M | -79.13% |
| 2018 | $1.31B | -13.92% |
| 2017 | $1.52B | 64.94% |
| 2016 | $919.84M | -66.42% |
| 2015 | $2.74B | - |
ADAP Market Cap Today is $131.50M -1.53% - 18 Jan 2025
View largest stocks by market cap 
